Reasons given by patients for participating, or not, in Phase 1 cancer trials. by Catt, S, Langridge, C, Fallowfield, L, Talbot, D, Jenkins, V

The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial by Leonard R, Yellowlees A, Mansi J, Fallowfield L, Jenkins V

Get full text

What oncologists believe they said and what patients believe they heard: an analysis of phase I trial discussions. by Jenkins, V, Solis-Trapala, I, Langridge, C, Catt, S, Talbot, D, Fallowfield, L

Communication and patient comprehension of phase 1 oncology trials: Results of a pilot study by Fleissig, A, Jenkins, V, Catt, S, Talbot, D, Cane, R, Langridge, C, Fallowfield, L

The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. by Jenkins, V, Farewell, D, Batt, L, Maughan, T, Branston, L, Langridge, C, Parlour, L, Farewell, V, Fallowfield, L

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial by Torr, B, Jones, C, Kavanaugh, G, Hamill, M, Allen, S, Choi, S, Garrett, A, Valganon-Petrizan, M, MacMahon, S, Yuan, L, Way, R, Harder, H, Gold, R, Taylor, A, Gabe, R, Lucassen, A, Manchanda, R, Fallowfield, L, Jenkins, V, Gandhi, A, Evans, DG, George, A, Hubank, M, Kemp, Z